Portfolio comparison
Johns Hopkins University vs Curevac SE
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Johns Hopkins University
Patents indexed
2
Year range
2002 – 2018
Most recent
2018
biotechpharmaceutical
Top Patents2 enriched
US 6458360· 2002
How to Create Lab-Made Proteins That Stop Immune System Overreaction
US RE46907· 2018
Using Plant-Derived Chemicals and Metabolic Drugs to Fight Cancer
Activity by Decade
2000s1
2010s1
Company B
Curevac SE
Patents indexed
2
Year range
2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingimmunotherapy
Top Patents2 enriched
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.